Plasma ß-amyloid and cognitive decline. - Wikidata - awgldk - TriplyDB

Plasma ß-amyloid and cognitive decline.

Plasma ß-amyloid and cognitive decline.

http://www.wikidata.org/entity/Q34424794

about

Prenatal lead levels, plasma amyloid β levels, and gene expression in young adulthood A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer's disease Body fluid biomarkers in Alzheimer's disease Association between IgM anti-herpes simplex virus and plasma amyloid-beta levels Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment.Abnormal amyloid β42 expression and increased oxidative stress in plasma of CKD patients with cognitive dysfunction: A small scale case control study comparison with Alzheimer's disease.Chronic dietary supplementation of 4% figs on the modification of oxidative stress in Alzheimer's disease transgenic mouse model.Biomarkers of Alzheimer's disease risk in peripheral tissues; focus on buccal cells.A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study.Long-term dietary supplementation of pomegranates, figs and dates alleviate neuroinflammation in a transgenic mouse model of Alzheimer's disease.The diagnostic value of controlled oral word association test-FAS and category fluency in single-domain amnestic mild cognitive impairment.Diet rich in date palm fruits improves memory, learning and reduces beta amyloid in transgenic mouse model of Alzheimer's disease.Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI Verbal serial list learning in mild cognitive impairment: a profile analysis of interference, forgetting, and errors Nutrient intake and plasma β-amyloid.Meta-analysis of amyloid-cognition relations in cognitively normal older adults Cognition in non-demented diabetic older adults Underrepresentation of African-Americans in Alzheimer's Trials: A Call for Affirmative Action Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans.Plasma amyloid-β levels and prognosis in incident dementia cases of the 3-City Study Using cognitive decline in novel trial designs for primary prevention and early disease-modifying therapy trials of Alzheimer's disease.Meta-analysis of plasma amyloid-β levels in Alzheimer's disease.Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes.Longitudinal Cognitive Profiles in Diabetes: Results From the National Alzheimer's Coordinating Center's Uniform Data.Physical activity predicts reduced plasma β amyloid in the Cardiovascular Health Study.Dogs with Cognitive Dysfunction as a Spontaneous Model for Early Alzheimer's Disease: A Translational Study of Neuropathological and Inflammatory Markers.Regional Hippocampal Atrophy and Higher Levels of Plasma Amyloid-Beta Are Associated With Subjective Memory Complaints in Nondemented Elderly Subjects.MER5101, a novel Aβ1-15:DT conjugate vaccine, generates a robust anti-Aβ antibody response and attenuates Aβ pathology and cognitive deficits in APPswe/PS1ΔE9 transgenic mice Levels of amyloid beta-42, interleukin-6 and tumor necrosis factor-alpha in Alzheimer's disease and vascular dementia.Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing.The clinical significance of plasma clusterin and Aβ in the longitudinal follow-up of patients with Alzheimer's disease.Potential blood biomarker for disease severity in the Taiwanese population with Alzheimer's disease.Association of Plasma β-Amyloid with Cognitive Performance and Decline in Chronic Kidney Disease.Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study.

P2860

Q24288814-6D7B59E5-F824-48A7-82C9-965A37892551 Q26771808-D80A8076-1FCC-4E87-AFC3-1690E7314473 Q26830098-F7A80DBA-95D4-46E4-BC8A-524463E0BAB3 Q28740764-383DE479-D5A6-456D-8359-EC2776552715 Q30052936-09FB0599-7531-4D1F-9DB3-B6CF5FCDB202 Q33854028-86699F99-18E8-46FA-B147-738E16F24CEB Q33876485-90DC9F88-BB33-4A8B-9B70-879C6F0B519D Q34201730-14F74578-5EF3-4526-A606-A77A87456F1D Q34341870-FAE644D4-FCE5-455A-A1C4-D88E2EE69ED7 Q35216988-FB92D4D2-EFD6-4BC4-B304-9A2B070083DB Q35649430-5B5D4E97-BC8C-4D6B-83C8-F186EEBB825F Q35792238-B0363EC1-573E-4A60-A903-6FDC24E4EBD6 Q35821382-B65E7210-A54A-4B91-B273-615EF017912B Q35860496-281EA2C0-EDCD-479A-ADF0-BCB61127ACD7 Q36014708-24295400-AA38-40C6-AC8D-858A61EDA0AE Q36850873-B247CAA7-79A7-478E-A1E8-8ADE885CB6BD Q36859533-5FF82CCA-E55D-4304-A8A2-8B33456EBEBB Q36963815-90E0C029-E797-44AB-BBD4-F61DC7A927E1 Q36998414-7F5EC802-28BB-4E8D-B504-BB12C81B11EC Q37451440-2DE851E2-7B28-4DC2-B1B5-C7220DB51CF8 Q37693190-7854CF4D-B556-4C40-A2DD-7D1ACEE7EDD4 Q37863247-A9FDF124-F45C-4CDF-973E-291FEFF14E6D Q37895050-EC95F05E-09EE-4CD4-9643-CD1A009B3D97 Q38125769-489B70D8-A5BB-4CB2-942C-79096E593791 Q38644254-B2BA31C8-8C66-45F3-94B8-03D52A055C6F Q38793329-4CF1773E-6FA6-4143-A2BC-B5BE27836867 Q40839177-967A724A-4694-464C-89DB-3879DCDB4789 Q40870087-30FCD4F0-84D5-4404-AF59-CBCBC37F6A4E Q41983452-B888DD1C-67A4-4B29-973A-1503C10CC033 Q44884500-692E1C89-5DE5-47C1-B935-7E273A0E5826 Q46397777-CFE73222-ACE2-4AFF-B72D-5AE1EFFC7260 Q47155881-5CC0573E-FC92-4D44-BF6C-F016F6ABA2BF Q48257794-5A1FFDC5-EA86-48D9-91E3-8C06132A7DE7 Q48450061-ACBF7956-FDF5-4BC4-A7C5-C175B70430A7 Q55516241-99156E83-E5BB-41E9-A75F-867CFD7CAD1D

P2860

Plasma ß-amyloid and cognitive decline.

http://www.wikidata.org/entity/Q34424794

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Plasma ß-amyloid and cognitive decline.

@ast

Plasma ß-amyloid and cognitive decline.

@en

Plasma ß-amyloid and cognitive decline.

@nl

type

label

Plasma ß-amyloid and cognitive decline.

@ast

Plasma ß-amyloid and cognitive decline.

@en

Plasma ß-amyloid and cognitive decline.

@nl

prefLabel

Plasma ß-amyloid and cognitive decline.

@ast

Plasma ß-amyloid and cognitive decline.

@en

Plasma ß-amyloid and cognitive decline.

@nl

P1433

Q34424794-830A4148-9FE9-47EE-B179-2EA8DBDE4CD6

P1476

Q34424794-35CB3167-1308-4795-B4C8-4E70C3111F90

P2093

Q34424794-325BCBA9-BB1A-44FA-8E68-E92B590569A1

Q34424794-352DCC7B-8D86-4C3C-B2E4-6481C26B113F

Q34424794-583CEA1C-8BFE-462C-B1E7-2A6DD7C551E5

Q34424794-618018BF-0D80-4002-ADE6-7D0409F3C910

Q34424794-6237C719-9EA6-4AD8-BC0A-5BDF4D190A03

Q34424794-A620B23E-5A3F-4011-810F-A15F081884A5

Q34424794-F6F90565-CA9F-437A-BACF-64BCBEC21EF0

P2860

Q34424794-0643DFF1-3A1C-4996-8DA1-0D95CCE6FD12

Q34424794-25E8085C-ACC9-4A13-A026-A334095CB621

Q34424794-2BB3B256-11FD-40CB-8580-89E32D9CCFBB

Q34424794-357CFAEC-B459-4C8F-BC62-83F1A7248EBC

Q34424794-3A8BF355-89B6-482C-9EE9-E2E33DFE7139

Q34424794-3F975871-76B2-401A-AC6A-B7C2E1FFF43B

Q34424794-4B1A25AC-F4E2-4E26-8AF1-35B0D7E45C2C

Q34424794-4D460478-F0F2-400C-91D0-A37CD75A00ED

Q34424794-4E5056E1-6280-4BE6-AB24-E215DC31B0C2

Q34424794-5A377560-4F5C-422E-8AAD-83E52EAA7306

P304

Q34424794-0A7879DB-4EBE-4CF8-B8B6-BD00D710E7A0

P31

Q34424794-3263BF9D-6561-456D-873C-CD3BF9CAFB61

P356

Q34424794-D60B4B84-6905-408D-A583-80D1887EAE81

P433

Q34424794-8A78842B-7354-4A49-9898-BBF8667A3F31

P478

Q34424794-5E284C17-F21A-4066-A53D-6465CE9BFEC8

P50

Q34424794-96A6D494-9655-47D8-81C3-56C7498EBCFE

P577

Q34424794-96FA4EE8-E9FB-4C76-9AA7-8C1D76221EC5

P5875

Q34424794-1D0CA5DD-CBCA-44C2-A61C-4889EE9CC0BD

P698

Q34424794-90F69590-9AD2-4A9A-A168-8871DD942022

P932

Q34424794-C9937638-8FC9-4DDE-9BC2-448D05594B50

P356

ARCHNEUROL.2010.189

P1433

P1476

Plasma ß-amyloid and cognitive decline.

@en

P2093

Elisaveta Sokolov

http://www.w3.org/2001/XMLSchema#string

Jennifer J Manly

http://www.w3.org/2001/XMLSchema#string

Ming Xin Tang

http://www.w3.org/2001/XMLSchema#string

Nicole Schupf

http://www.w3.org/2001/XMLSchema#string

Nikolaos Scarmeas

http://www.w3.org/2001/XMLSchema#string

Richard P Mayeux

http://www.w3.org/2001/XMLSchema#string

Stephanie A Cosentino

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Influence of education and occupation on the incidence of Alzheimer's disease

Alzheimer's disease: the amyloid cascade hypothesis

Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.

Education and rates of cognitive decline in incident Alzheimer's disease

The molecular pathology of Alzheimer's disease.

Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease

Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort study.

Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects.

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.

P304

1485-1490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHNEUROL.2010.189

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45583476

http://www.w3.org/2001/XMLSchema#string

P698

20697031

http://www.w3.org/2001/XMLSchema#string

P932

3006003

http://www.w3.org/2001/XMLSchema#string